Globe News Wire · RO.SW · October 27, 2026
Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: Globe News Wire ↗